Condition
Fish Allergy
Total Trials
4
Recruiting
0
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Completed2
Active Not Recruiting1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07727148Not Yet RecruitingPrimary
FASC: Fish Allergy in Spanish Children - A Study of New Cases of Fish Allergy in Children and Adolescents
NCT05590299Not ApplicableActive Not RecruitingPrimary
Fish Oral Immunotherapy in Hong Kong Children
NCT02365168Not ApplicableCompletedPrimary
Allergy Against Different Species of Fish in Children and Adolescents Allergic to Fish
NCT02017626Phase 1CompletedPrimary
FAST-Fish -Food Allergy Specific Treatment for Fish Allergy.
Showing all 4 trials